ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Enzalutamide Tablets Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-27D18142
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Enzalutamide Tablets Market Research Report 2024
BUY CHAPTERS

Global Enzalutamide Tablets Market Research Report 2024

Code: QYRE-Auto-27D18142
Report
October 2024
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aurisco
Astellas/Pfizer

Enzalutamide Tablets Market

Enzalutamide is an active pharmaceutical ingredient (API) used primarily in the treatment of prostate cancer. It is an androgen receptor inhibitor that works by blocking the action of androgens (male hormones like testosterone) on cancer cells, which can help slow the growth and spread of tumors.
The global Enzalutamide Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Enzalutamide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enzalutamide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Enzalutamide Tablets include Astellas/Pfizer, AURISCO, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enzalutamide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzalutamide Tablets.
The Enzalutamide Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Enzalutamide Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enzalutamide Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Enzalutamide Tablets Market Report

Report Metric Details
Report Name Enzalutamide Tablets Market
Segment by Type
  • 40mg
  • 80mg
Segment by Application
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • Castration- Resistant Prostate Cancer (NM-CRPC)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astellas/Pfizer, AURISCO
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Enzalutamide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Enzalutamide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Enzalutamide Tablets Market report?

Ans: The main players in the Enzalutamide Tablets Market are Astellas/Pfizer, AURISCO

What are the Application segmentation covered in the Enzalutamide Tablets Market report?

Ans: The Applications covered in the Enzalutamide Tablets Market report are Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Castration- Resistant Prostate Cancer (NM-CRPC)

What are the Type segmentation covered in the Enzalutamide Tablets Market report?

Ans: The Types covered in the Enzalutamide Tablets Market report are 40mg, 80mg

Recommended Reports

Prostate Cancer Markets

Hormone Oncology Drugs

Urological & Reproductive Drugs

1 Enzalutamide Tablets Market Overview
1.1 Product Definition
1.2 Enzalutamide Tablets by Type
1.2.1 Global Enzalutamide Tablets Market Value Comparison by Type (2024-2030)
1.2.2 40mg
1.2.3 80mg
1.3 Enzalutamide Tablets by Application
1.3.1 Global Enzalutamide Tablets Market Value by Application (2024-2030)
1.3.2 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1.3.3 Castration- Resistant Prostate Cancer (NM-CRPC)
1.4 Global Enzalutamide Tablets Market Size Estimates and Forecasts
1.4.1 Global Enzalutamide Tablets Revenue 2019-2030
1.4.2 Global Enzalutamide Tablets Sales 2019-2030
1.4.3 Global Enzalutamide Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enzalutamide Tablets Market Competition by Manufacturers
2.1 Global Enzalutamide Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enzalutamide Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enzalutamide Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Enzalutamide Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enzalutamide Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enzalutamide Tablets, Product Type & Application
2.7 Global Key Manufacturers of Enzalutamide Tablets, Date of Enter into This Industry
2.8 Global Enzalutamide Tablets Market Competitive Situation and Trends
2.8.1 Global Enzalutamide Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Enzalutamide Tablets Players Market Share by Revenue
2.8.3 Global Enzalutamide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Enzalutamide Tablets Market Scenario by Region
3.1 Global Enzalutamide Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enzalutamide Tablets Sales by Region: 2019-2030
3.2.1 Global Enzalutamide Tablets Sales by Region: 2019-2024
3.2.2 Global Enzalutamide Tablets Sales by Region: 2025-2030
3.3 Global Enzalutamide Tablets Revenue by Region: 2019-2030
3.3.1 Global Enzalutamide Tablets Revenue by Region: 2019-2024
3.3.2 Global Enzalutamide Tablets Revenue by Region: 2025-2030
3.4 North America Enzalutamide Tablets Market Facts & Figures by Country
3.4.1 North America Enzalutamide Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enzalutamide Tablets Sales by Country (2019-2030)
3.4.3 North America Enzalutamide Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enzalutamide Tablets Market Facts & Figures by Country
3.5.1 Europe Enzalutamide Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enzalutamide Tablets Sales by Country (2019-2030)
3.5.3 Europe Enzalutamide Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enzalutamide Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Enzalutamide Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enzalutamide Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Enzalutamide Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Enzalutamide Tablets Market Facts & Figures by Country
3.7.1 Latin America Enzalutamide Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enzalutamide Tablets Sales by Country (2019-2030)
3.7.3 Latin America Enzalutamide Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Enzalutamide Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Enzalutamide Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enzalutamide Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enzalutamide Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enzalutamide Tablets Sales by Type (2019-2030)
4.1.1 Global Enzalutamide Tablets Sales by Type (2019-2024)
4.1.2 Global Enzalutamide Tablets Sales by Type (2025-2030)
4.1.3 Global Enzalutamide Tablets Sales Market Share by Type (2019-2030)
4.2 Global Enzalutamide Tablets Revenue by Type (2019-2030)
4.2.1 Global Enzalutamide Tablets Revenue by Type (2019-2024)
4.2.2 Global Enzalutamide Tablets Revenue by Type (2025-2030)
4.2.3 Global Enzalutamide Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Enzalutamide Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enzalutamide Tablets Sales by Application (2019-2030)
5.1.1 Global Enzalutamide Tablets Sales by Application (2019-2024)
5.1.2 Global Enzalutamide Tablets Sales by Application (2025-2030)
5.1.3 Global Enzalutamide Tablets Sales Market Share by Application (2019-2030)
5.2 Global Enzalutamide Tablets Revenue by Application (2019-2030)
5.2.1 Global Enzalutamide Tablets Revenue by Application (2019-2024)
5.2.2 Global Enzalutamide Tablets Revenue by Application (2025-2030)
5.2.3 Global Enzalutamide Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Enzalutamide Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas/Pfizer
6.1.1 Astellas/Pfizer Company Information
6.1.2 Astellas/Pfizer Description and Business Overview
6.1.3 Astellas/Pfizer Enzalutamide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas/Pfizer Enzalutamide Tablets Product Portfolio
6.1.5 Astellas/Pfizer Recent Developments/Updates
6.2 AURISCO
6.2.1 AURISCO Company Information
6.2.2 AURISCO Description and Business Overview
6.2.3 AURISCO Enzalutamide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AURISCO Enzalutamide Tablets Product Portfolio
6.2.5 AURISCO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enzalutamide Tablets Industry Chain Analysis
7.2 Enzalutamide Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enzalutamide Tablets Production Mode & Process
7.4 Enzalutamide Tablets Sales and Marketing
7.4.1 Enzalutamide Tablets Sales Channels
7.4.2 Enzalutamide Tablets Distributors
7.5 Enzalutamide Tablets Customers
8 Enzalutamide Tablets Market Dynamics
8.1 Enzalutamide Tablets Industry Trends
8.2 Enzalutamide Tablets Market Drivers
8.3 Enzalutamide Tablets Market Challenges
8.4 Enzalutamide Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Aurisco
Astellas/Pfizer
List of Tables
 Table 1. Global Enzalutamide Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Enzalutamide Tablets Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Enzalutamide Tablets Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Enzalutamide Tablets Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Enzalutamide Tablets Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Enzalutamide Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Enzalutamide Tablets Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Enzalutamide Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Enzalutamide Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Enzalutamide Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Enzalutamide Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Enzalutamide Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Enzalutamide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzalutamide Tablets as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Enzalutamide Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Enzalutamide Tablets Sales by Region (2019-2024) & (K Units)
 Table 18. Global Enzalutamide Tablets Sales Market Share by Region (2019-2024)
 Table 19. Global Enzalutamide Tablets Sales by Region (2025-2030) & (K Units)
 Table 20. Global Enzalutamide Tablets Sales Market Share by Region (2025-2030)
 Table 21. Global Enzalutamide Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Enzalutamide Tablets Revenue Market Share by Region (2019-2024)
 Table 23. Global Enzalutamide Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Enzalutamide Tablets Revenue Market Share by Region (2025-2030)
 Table 25. North America Enzalutamide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Enzalutamide Tablets Sales by Country (2019-2024) & (K Units)
 Table 27. North America Enzalutamide Tablets Sales by Country (2025-2030) & (K Units)
 Table 28. North America Enzalutamide Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Enzalutamide Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Enzalutamide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Enzalutamide Tablets Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Enzalutamide Tablets Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Enzalutamide Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Enzalutamide Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Enzalutamide Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Enzalutamide Tablets Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Enzalutamide Tablets Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Enzalutamide Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Enzalutamide Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Enzalutamide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Enzalutamide Tablets Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Enzalutamide Tablets Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Enzalutamide Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Enzalutamide Tablets Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Enzalutamide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Enzalutamide Tablets Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Enzalutamide Tablets Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Enzalutamide Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Enzalutamide Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Enzalutamide Tablets Sales (K Units) by Type (2019-2024)
 Table 51. Global Enzalutamide Tablets Sales (K Units) by Type (2025-2030)
 Table 52. Global Enzalutamide Tablets Sales Market Share by Type (2019-2024)
 Table 53. Global Enzalutamide Tablets Sales Market Share by Type (2025-2030)
 Table 54. Global Enzalutamide Tablets Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Enzalutamide Tablets Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Enzalutamide Tablets Revenue Market Share by Type (2019-2024)
 Table 57. Global Enzalutamide Tablets Revenue Market Share by Type (2025-2030)
 Table 58. Global Enzalutamide Tablets Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Enzalutamide Tablets Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Enzalutamide Tablets Sales (K Units) by Application (2019-2024)
 Table 61. Global Enzalutamide Tablets Sales (K Units) by Application (2025-2030)
 Table 62. Global Enzalutamide Tablets Sales Market Share by Application (2019-2024)
 Table 63. Global Enzalutamide Tablets Sales Market Share by Application (2025-2030)
 Table 64. Global Enzalutamide Tablets Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Enzalutamide Tablets Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Enzalutamide Tablets Revenue Market Share by Application (2019-2024)
 Table 67. Global Enzalutamide Tablets Revenue Market Share by Application (2025-2030)
 Table 68. Global Enzalutamide Tablets Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Enzalutamide Tablets Price (US$/Unit) by Application (2025-2030)
 Table 70. Astellas/Pfizer Company Information
 Table 71. Astellas/Pfizer Description and Business Overview
 Table 72. Astellas/Pfizer Enzalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Astellas/Pfizer Enzalutamide Tablets Product
 Table 74. Astellas/Pfizer Recent Developments/Updates
 Table 75. AURISCO Company Information
 Table 76. AURISCO Description and Business Overview
 Table 77. AURISCO Enzalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. AURISCO Enzalutamide Tablets Product
 Table 79. AURISCO Recent Developments/Updates
 Table 80. Key Raw Materials Lists
 Table 81. Raw Materials Key Suppliers Lists
 Table 82. Enzalutamide Tablets Distributors List
 Table 83. Enzalutamide Tablets Customers List
 Table 84. Enzalutamide Tablets Market Trends
 Table 85. Enzalutamide Tablets Market Drivers
 Table 86. Enzalutamide Tablets Market Challenges
 Table 87. Enzalutamide Tablets Market Restraints
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Enzalutamide Tablets
 Figure 2. Global Enzalutamide Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Enzalutamide Tablets Market Share by Type: 2023 & 2030
 Figure 4. 40mg Product Picture
 Figure 5. 80mg Product Picture
 Figure 6. Global Enzalutamide Tablets Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Enzalutamide Tablets Market Share by Application: 2023 & 2030
 Figure 8. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
 Figure 9. Castration- Resistant Prostate Cancer (NM-CRPC)
 Figure 10. Global Enzalutamide Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Enzalutamide Tablets Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Enzalutamide Tablets Sales (2019-2030) & (K Units)
 Figure 13. Global Enzalutamide Tablets Average Price (US$/Unit) & (2019-2030)
 Figure 14. Enzalutamide Tablets Report Years Considered
 Figure 15. Enzalutamide Tablets Sales Share by Manufacturers in 2023
 Figure 16. Global Enzalutamide Tablets Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Enzalutamide Tablets Players: Market Share by Revenue in Enzalutamide Tablets in 2023
 Figure 18. Enzalutamide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Enzalutamide Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Enzalutamide Tablets Sales Market Share by Country (2019-2030)
 Figure 21. North America Enzalutamide Tablets Revenue Market Share by Country (2019-2030)
 Figure 22. United States Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Enzalutamide Tablets Sales Market Share by Country (2019-2030)
 Figure 25. Europe Enzalutamide Tablets Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Enzalutamide Tablets Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Enzalutamide Tablets Revenue Market Share by Region (2019-2030)
 Figure 33. China Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Enzalutamide Tablets Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Enzalutamide Tablets Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Enzalutamide Tablets Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Enzalutamide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Enzalutamide Tablets by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Enzalutamide Tablets by Type (2019-2030)
 Figure 52. Global Enzalutamide Tablets Price (US$/Unit) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Enzalutamide Tablets by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Enzalutamide Tablets by Application (2019-2030)
 Figure 55. Global Enzalutamide Tablets Price (US$/Unit) by Application (2019-2030)
 Figure 56. Enzalutamide Tablets Value Chain
 Figure 57. Enzalutamide Tablets Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Enzalutamide API Market
Global Oncology API Market Research Report 2024
Global Finasteride API Market Research Report 2024
Finasteride Oral Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anastrozole APl Market Research Report 2024
Global Finasteride Oral Route Market Research Report 2024
Global Ceritinib API Market Research Report 2024
Global Neratinib Maleate Tablets Market Research Report 2024
Global 5α Reductase Inhibitors Market Research Report 2025
Global Androgen Receptor AR Antagonist Market Research Report 2024
Global Afatinib API Market Research Report 2024
Global Enanton Leucorin Acetate Market Research Report 2024
Global Dutasteride API Market Research Report 2024
Global Sacubitril Valsartan API Market Research Report 2025
Global Bicalutamide Market Research Report 2024
Global Nilutamide Market Research Report 2024
Testosterone Blocker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostate Cancer Medicine Market Insights Forecast to 2030
Global Aromatase Inhibitors Market Research Report 2024
Relugolix API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions